|
|
Genes with expression 1.5X depleted in PVD and OLL neurons. |
Data sets were normalized by RMA and transcripts showing relative PVD enrichment (>=1.5X) vs. the reference sample were identified by SAM analysis (False Discovery Rate, FDR < 1%) |
WBPaper00036375:depleted_in_PVD_OLL
|
|
|
Transcripts that showed significantly decreased expression in daf-2(e1370) comparing to in N2. |
Student's t-test, fold change > 2, p-value < 0.05. |
WBPaper00055386:daf-2(e1370)_downregulated
|
|
|
Transcripts that showed significantly decreased expression in eat-2(ad465) comparing to in N2. |
Student's t-test, fold change > 2, p-value < 0.05. |
WBPaper00055386:eat-2(ad465)_downregulated
|
|
|
Transcripts of noncoding genes that showed significantly increased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_enriched_noncoding-RNA
|
|
|
mRNAs that showed increased expression after 100ug\/L microcystin-LR exposure. |
Differentially expressed genes (DEGs) were identified with a random-variance t-test and an SAM (Significance Analysis of Microarrays) test. Gene expression differences were considered statistically significant if their p-value was less than 0.05, the false discovery rate less than 0.3 and the fold-change compared to control at least <= 0.67 or >= 1.5. |
WBPaper00045807:microcystin-LR_upregulated
|
|
|
Genes that showed increased expression after 50uM TBBP treatment comparing with control. |
Differentially expressed genes (DEGs) were identified with a random variance t test and a significance analysis of microarrays (SAM) test. Genes were considered statistically significant if their p value was less than 0.05, the false discovery rate less than 0.3 and the fold change compared to control at least <= 0.67 or >= 1.5. |
WBPaper00045294:50uM_TBBP_upregulated
|
